Who invested in Magnolia NeuroSciences?
Magnolia NeuroSciences's investors include ARCH Venture Partners, Alexandria Venture Investments, Lilly Asia Ventures and AbbVie.

Funding summaryUpdated 26 Oct 2026
$18Mraised across 1 round since 2020, from 1 source
Source recordedSEC filing: $5.0M sold, first sale Jul 2020
From the SEC filings it signed: 3 on the team.
On the board, as filediAlice LyMichael BaranSteve Gillis
Magnolia NeuroSciences's investors include ARCH Venture Partners, Alexandria Venture Investments, Lilly Asia Ventures and AbbVie.
Magnolia NeuroSciences has raised $18M across 1 round since 2020.
Magnolia NeuroSciences's most recent round was a Venture of $18M in Jul 2020.
Its most recent round, $18M in Jul 2020, is also its largest on record.
Magnolia NeuroSciences's first round on record, in Jul 2020, was backed by ARCH Venture Partners, Alexandria Venture Investments and Lilly Asia Ventures and 1 others.
Magnolia NeuroSciences's latest named round is a Venture, in Jul 2020.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.